Exhibit 10.2
VOTING AGREEMENT
This Voting Agreement (this “Voting Agreement”), dated February 8, 2022, is being delivered to you in connection with an understanding by and between Zosano Pharma Corporation, a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto.
Reference is hereby made to the public offering (the “Offering”) of units (the “Units”), each unit consisting of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock,” and together with any shares of common stock issuable pursuant to the Series F Warrants included in the Units, the “Shares”), and one Series F Warrant to purchase one share of common stock pursuant to the registration statement on Form S-3 (File No. 333-257682) (“Registration Statement”) and the prospectus supplement related to the Offering. The Company is requiring a voting agreement in substance the same as this Voting Agreement from all purchasers that purchase in excess of $250,000 of Units in the Offering (each a “Holder,” and collectively, the “Holders”).
The Holder agrees to vote all shares of the Company’s common stock it beneficially owns, including the Common Stock (the “Voting Shares”), as of the record date for the Company’s next meeting of its stockholders, February 10, 2022, with respect to all of the proposals presented by the Company to the stockholders of the Company at such meeting, including at every adjournment or postponement thereof, or any subsequent meeting of its stockholders duly called for the same or similar purposes. For clarity, the Holder’s agreement to vote its Voting Shares in accordance with the immediately preceding sentence does not require the Holder to vote such shares for or against any particular proposal or proposals, whether or not such proposal or proposals are recommended by the Company’s board of directors.
No material, non-public information has been provided to the Holder by the Company or any of its subsidiaries or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by this Voting Agreement. As of the date hereof, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, if any, whether written or oral, between the Company, any of its subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the Holder or any of its affiliates, on the other hand, with respect to this Voting Agreement and the transactions contemplated hereby shall terminate.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Voting Agreement must be in writing and shall be delivered to the Holder at the e-mail address or facsimile number on the signature page hereto.
This Voting Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior negotiations, letters and understandings relating to the subject matter hereof and are fully binding on the parties hereto.
This Voting Agreement may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and all such counterparts shall constitute one and the same instrument. This Voting Agreement may be executed and accepted by facsimile or PDF signature and any such signature shall be of the same force and effect as an original signature.
The terms of this Voting Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective successors and assigns.
This Voting Agreement may not be amended or modified except in writing signed by each of the parties hereto.
All questions concerning the construction, validity, enforcement and interpretation of this Voting Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.